Pricing Log in Create free account

Sarepta Therapeutics, Inc. (SRPT) vs Trevi Therapeutics, Inc. (TRVI)

Sarepta Therapeutics, Inc. and Trevi Therapeutics, Inc. are both Biotechnology companies. Sarepta Therapeutics, Inc. and Trevi Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Trevi Therapeutics, Inc. has the higher net margin (0.00% vs −5.86%) and the lower return on invested capital (−1,412.1% vs −2.03%). Across the 13 metrics below, Sarepta Therapeutics, Inc. leads on 7 and Trevi Therapeutics, Inc. on 6.

Valuation

Metric SRPT TRVI Biotechnology median
P/E n/m n/m 10.60
P/S 0.96 n/m 9.40
P/B 1.23 6.93 2.13
Price to free cash flow 11.07 n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.95 n/m 9.02
Earnings yield (6.21%) (2.39%) (32.88%)
Free cash flow yield 9.04% (2.37%) (23.13%)

Profitability

Metric SRPT TRVI Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin (2.50%) 0.00% 0.00%
Net margin (5.86%) 0.00% 0.00%
Free cash flow margin 9.02% 0.00% 0.00%
Return on equity (8.05%) (19.66%) (51.96%)
Return on assets (3.44%) (18.97%) (46.06%)
Return on invested capital (2.03%) (1,412.11%) 0.00%

Growth

Metric SRPT TRVI Biotechnology median
Revenue growth (TTM) (18.95%) — 6.76%
EPS growth (last fiscal year) (404.70%) 31.91% 29.88%
Revenue growth, 5-year CAGR 32.41% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SRPT TRVI Biotechnology median
Debt to equity 0.56 0.00 0.00
Current ratio 3.46 37.28 4.97
Net debt to EBITDA 0.17 3.83 1.01

Dividend

Metric SRPT TRVI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SRPT TRVI Biotechnology median
Market cap 1.86b 1.83b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack